A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)

Clinical trial NCT00764946 · COMPLETED

Trial details

NCT number: NCT00764946
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Immunodeficiency Virus

Start date: 2008-10-01
Primary completion: 2011-02-01
Enrollment: 209

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.